Abstract:Introduction: Target therapy for cancer cell mutation has brought attention to several challenges in clinical applications, including limited therapeutic targets, less patient benefits, and susceptibility to acquired due to their clear biological mechanisms and high specificity in targeting cancers with specific mutations. However, the identification of truly lethal synthetic lethal therapeutic targets for cancer cells remains uncommon, primarily due to compensatory mechanisms. Methods: In our pursuit of core therapeutic targets (CTTs) that exhibit extensive synthetic lethality in cancer and the corresponding potential drugs, we have developed a machine-learning model that utilizes multiple levels and dimensions of cancer characterization. This is achieved through the consideration of the transcriptional and post-transcriptional regulation of cancer-specific genes and the construction of a model that integrates statistics and machine learning. The model incorporates statistics such as Wilcoxon and Pearson, as well as random forest. Through WGCNA and network analysis, we identify hub genes in the SL network that serve as CTTs. Additionally, we establish regulatory networks for non-coding RNA (ncRNA) and drug-target interactions. Results: Our model has uncovered 7277 potential SL interactions, while WGCNA has identified 13 gene modules. Through network analysis, we have identified 30 CTTs with the highest degree in these modules. Based on these CTTs, we have constructed networks for ncRNA regulation and drug targets. Furthermore, by applying the same process to lung cancer and renal cell carcinoma, we have identified corresponding CTTs and potential therapeutic drugs. We have also analyzed common therapeutic targets among all three cancers. Discussion: The results of our study have broad applicability across various dimensions and histological data, as our model identifies potential therapeutic targets by learning multidimensional complex features from known synthetic lethal gene pairs. The incorporation of statistical screening and network analysis further enhances the confidence in these potential targets. Our approach provides novel theoretical insights and methodological support for the identification of CTTs and drugs in diverse types of cancer.

Prioritizing functional modules mediating genetic perturbations and their phenotypic effects: a global strategy

Functional variomics and network perturbation: connecting genotype to phenotype in cancer

Towards Prediction and Prioritization of Disease Genes by the Modularity of Human Phenome-Genome Assembled Network.

Towards Identification of Human Disease Phenotype-Genotype Association via a Network-Module Based Method

Identification of Optimal Strategies for State Transition of Complex Biological Networks.

Uncover Disease Genes by Maximizing Information Flow in the Phenome-Interactome Network.

Nonparametric Functional Mapping of Quantitative Trait Loci Underlying Programmed Cell Death.

Identification of breast cancer risk modules via an integrated strategy

Exploring Phenotype-Associated Modules in an Oral Cavity Tumor Using an Integrated Framework

Potential Pathogenic Genes Prioritization Based on Protein Domain Interaction Network Analysis.

Prioritizing cancer lncRNA modulators via integrated lncRNA-mRNA network and somatic mutation data

A graph theoretical approach to experimental prioritization in genome-scale investigations

A network-based machine-learning framework to identify both functional modules and disease genes

Functional Dissection of Regulatory Models Using Gene Expression Data of Deletion Mutants.

A novel method of using Deep Belief Networks and genetic perturbation data to search for yeast signaling pathways

Multi-level characteristics recognition of cancer core therapeutic targets and drug screening for a broader patient population

e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks

Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes

Constructing Human Phenome-Interactome Networks for the Prioritization of Candidate Genes

Joint network and node selection for pathway-based genomic data analysis.

Integrating data and knowledge to identify functional modules of genes: a multilayer approach